Dr Reddy’s to launch 20 products in US in FY20
Dr Reddy’s on May 17 said it is planning to launch 20 products in the US and aims to maintain 50 percent plus gross margin in FY20. The company anticipates US FDA approval for generic Nuvaring, a contraceptive, in the first half of FY20. The US launch of generic Copaxone, used in the treatment of multiple … Read more